Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01453660 · ClinicalTrials.gov registry record
Acute Changes in Endothelial Function in Germ Cell Tumor Patients Treated With Cisplatin and Untreated Germ Cell Tumor Controls
A clinical trial of Germ Cell Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 44
- Enrollment target
- 1
- Study location
NCT01453660 is a study of Germ Cell Cancer that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 44 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01453660, a study of Germ Cell Cancer, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
Cisplatin is one of the most common chemotherapy drugs used to treat many different cancers, including germ cell tumors (GCT). Cisplatin is very effective in treating GCT, but there are side effects. One of the possible long-term side effects of cisplatin is thought to be heart disease. The way that cisplatin causes heart disease is not well understood. One possibility is that cisplatin may damage the inside layer of blood vessels called the endothelium. The purpose of this study is to measure changes in the endothelium that happen when patients with GCT get cisplatin chemotherapy and to compare these changes with a group of patients not receiving chemotherapy.
Conditions Studied
Interventions
- OTHER Endo-PAT2000 testing
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2011-10-11 |
| Est. Completion | 2026-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01453660
The ClinicalTrials.gov registry entry for NCT01453660 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Germ Cell Cancer appearing as the primary indexed condition, and to 1 intervention - of which Endo-PAT2000 testing is the first listed.
NCT01453660 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01453660 about?
NCT01453660 is a clinical study titled "Acute Changes in Endothelial Function in Germ Cell Tumor Patients Treated With Cisplatin and Untreated Germ Cell Tumor Controls". Cisplatin is one of the most common chemotherapy drugs used to treat many different cancers, including germ cell tumors (GCT). Cisplatin is very effective in treating GCT, but there are side effects. One of the possible long-term side effects of cisplatin is thought to be heart disease. The way that...
What is the current status of trial NCT01453660?
This trial is currently active not recruiting. The enrollment target is 44 participants. The study started on 2011-10-11. Estimated completion is 2026-10.
What conditions does trial NCT01453660 study?
This clinical trial studies the following conditions: Germ Cell Cancer.
What interventions are being tested in trial NCT01453660?
The interventions under investigation include: Endo-PAT2000 testing (OTHER).
Who is sponsoring clinical trial NCT01453660?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01453660 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Germ Cell Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.